Ultragenyx Pharmaceutical | Attività Correnti



Current Assets Cambiamento Data
Acadia Pharmaceuticals USD 960.55M 89.61M 2025-06
Agios Pharmaceuticals USD 1.02B 50.85M 2025-06
Alnylam Pharmaceuticals USD 3.64B 375.44M 2025-06
BioMarin Pharmaceutical USD 3.81B 337.43M 2025-06
Insmed USD 2.08B 678.89M 2025-06
Ionis Pharmaceuticals USD 2.58B 158.22M 2025-06
Kyowa Hakko Kirin JPY 490.86B 40.62B 2025-06
MacroGenics USD 217.49M 4.71M 2024-12
Moderna USD 6.17B 595M 2025-06
Neurocrine Biosciences USD 1.75B 111M 2025-06
PTC Therapeutics USD 2.27B 43.53M 2025-06
Regeneron Pharmaceuticals USD 16.86B 712.2M 2025-06
Sarepta Therapeutics USD 2.66B 224.45M 2025-06
Ultragenyx Pharmaceutical USD 719.79M 20.63M 2025-06
Vertex Pharmaceuticals USD 10.43B 419.1M 2025-06


Ultragenyx Pharmaceutical Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.